187 related articles for article (PubMed ID: 33745573)
1. A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older.
Kashiwagi K; Takayama M; Ichikawa H; Takaishi H; Iwao Y; Kanai T
Clin Nutr ESPEN; 2021 Apr; 42():166-172. PubMed ID: 33745573
[TBL] [Abstract][Full Text] [Related]
2. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women.
Ilich JZ; Inglis JE; Kelly OJ; McGee DL
Osteoporos Int; 2015 Nov; 26(11):2587-95. PubMed ID: 26025288
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of osteosarcopenic obesity in community-dwelling older adults: a cross-sectional retrospective study.
Kolbaşı EN; Demirdağ F
Arch Osteoporos; 2020 Oct; 15(1):166. PubMed ID: 33079259
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcopenic Obesity Associated with Poor Physical Performance in the Elderly Chinese Community.
Ma Y; Zhang W; Han P; Kohzuki M; Guo Q
Clin Interv Aging; 2020; 15():1343-1352. PubMed ID: 32848375
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonografically assessed osteosarcopenic obesity is associated with frailty in community-dwelling older adults.
Okyar Baş A; Güner Oytun M; Deniz O; Öztürk Y; Kahyaoğlu Z; Ceylan S; Çöteli S; Dikmeer A; İleri İ; Hafızoğlu M; Şahiner Z; Doğu BB; Cankurtaran M; Halil MG
Nutrition; 2022; 103-104():111827. PubMed ID: 36174393
[TBL] [Abstract][Full Text] [Related]
7. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
[TBL] [Abstract][Full Text] [Related]
8. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
[TBL] [Abstract][Full Text] [Related]
9. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcopenic obesity and its components-osteoporosis, sarcopenia, and obesity-are associated with blood cell count-derived inflammation indices in older Chinese people.
Nie YZ; Yan ZQ; Yin H; Shan LH; Wang JH; Wu QH
BMC Geriatr; 2022 Jun; 22(1):532. PubMed ID: 35764967
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenic Obesity in People with Alcoholic Use Disorder: Relation with Inflammation, Vascular Risk Factors and Serum Vitamin D Levels.
Martín-González C; Fernández-Alonso P; Pérez-Hernández O; Abreu-González P; Espelosín-Ortega E; Fernández-Rodríguez CM; Martín-Ponce E; González-Reimers E
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373124
[TBL] [Abstract][Full Text] [Related]
12. Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study.
Chen X; Kong C; Yu H; Gong J; Lan L; Zhou L; Gong J; Liu P; Xu L; Deng Q
BMJ Open; 2019 Jul; 9(7):e026818. PubMed ID: 31324680
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
14. Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis.
Song W; Yoo SH; Jang J; Baik SJ; Lee BK; Lee HW; Park JS
Gut Liver; 2023 Jan; 17(1):130-138. PubMed ID: 36472070
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program.
Ahmadinezhad M; Mansournia MA; Fahimfar N; Shafiee G; Nabipour I; Sanjari M; Khalagi K; Mansourzadeh MJ; Larijani B; Ostovar A
Arch Osteoporos; 2023 Nov; 18(1):137. PubMed ID: 37978092
[TBL] [Abstract][Full Text] [Related]
16. Discovering the Individualized Factors Associated with Sarcopenia and Sarcopenic Obesity Phenotypes-A Machine Learning Approach.
Moroni A; Perna S; Azzolino D; Gasparri C; Zupo R; Micheletti Cremasco M; Rondanelli M
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960189
[TBL] [Abstract][Full Text] [Related]
17. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcopenic Obesity: Prevalence and Relation With Frailty and Physical Performance in Middle-Aged and Older Women.
Szlejf C; Parra-Rodríguez L; Rosas-Carrasco O
J Am Med Dir Assoc; 2017 Aug; 18(8):733.e1-733.e5. PubMed ID: 28431912
[TBL] [Abstract][Full Text] [Related]
19. Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan.
Wijarnpreecha K; Aby ES; Ahmed A; Kim D
J Gastrointestin Liver Dis; 2021 Jun; 30(2):227-232. PubMed ID: 33951121
[TBL] [Abstract][Full Text] [Related]
20. Diet quality and osteosarcopenic obesity in community-dwelling adults 50 years and older.
Kim J; Lee Y; Kye S; Chung YS; Kim JH; Chon D; Lee KE
Maturitas; 2017 Oct; 104():73-79. PubMed ID: 28923178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
